ITMI20012025A0 - Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono - Google Patents

Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono

Info

Publication number
ITMI20012025A0
ITMI20012025A0 IT2001MI002025A ITMI20012025A ITMI20012025A0 IT MI20012025 A0 ITMI20012025 A0 IT MI20012025A0 IT 2001MI002025 A IT2001MI002025 A IT 2001MI002025A IT MI20012025 A ITMI20012025 A IT MI20012025A IT MI20012025 A0 ITMI20012025 A0 IT MI20012025A0
Authority
IT
Italy
Prior art keywords
aminoalkylammides
omega
aryl
contain
pharmaceutical compositions
Prior art date
Application number
IT2001MI002025A
Other languages
English (en)
Inventor
Maria Candida Cesta
Francesco Colotta
Riccardo Bertini
Cinzia Bizzarri
Marcello Allegretti
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Priority to IT2001MI002025A priority Critical patent/ITMI20012025A1/it
Publication of ITMI20012025A0 publication Critical patent/ITMI20012025A0/it
Priority to PCT/EP2002/010746 priority patent/WO2003029187A1/en
Priority to PT02777207T priority patent/PT1430020E/pt
Priority to US10/487,679 priority patent/US7026510B2/en
Priority to ES02777207.8T priority patent/ES2573531T3/es
Priority to JP2003532442A priority patent/JP4405801B2/ja
Priority to DK02777207.8T priority patent/DK1430020T3/en
Priority to RU2004113099/04A priority patent/RU2291857C2/ru
Priority to HU0401763A priority patent/HU230541B1/hu
Priority to SI200231073A priority patent/SI1430020T1/sl
Priority to EP02777207.8A priority patent/EP1430020B1/en
Priority to PL369511A priority patent/PL214275B1/pl
Priority to CA2458035A priority patent/CA2458035C/en
Priority to AU2002338784A priority patent/AU2002338784B2/en
Publication of ITMI20012025A1 publication Critical patent/ITMI20012025A1/it
Priority to NO20041609A priority patent/NO328879B1/no
Priority to CY20161100463T priority patent/CY1117657T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/44—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
IT2001MI002025A 2001-09-28 2001-09-28 Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono ITMI20012025A1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT2001MI002025A ITMI20012025A1 (it) 2001-09-28 2001-09-28 Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono
AU2002338784A AU2002338784B2 (en) 2001-09-28 2002-09-25 Quaternary ammonium salts of omega-aminoalkylamides of R-2-aryl-propionic acids and pharmaceutical compositions containing them
DK02777207.8T DK1430020T3 (en) 2001-09-28 2002-09-25 Quaternary ammonium salts of omega-AMINOALKYLAMIDER OF R-2-aryl-propionic acids and pharmaceutical compositions containing them,
HU0401763A HU230541B1 (hu) 2001-09-28 2002-09-25 R-2-aril-propionsavak omega-aminoalkilamidjai kvaterner ammóniumsói és e vegyületeket tartalmazó gyógyszerészeti készítmények
US10/487,679 US7026510B2 (en) 2001-09-28 2002-09-25 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them
ES02777207.8T ES2573531T3 (es) 2001-09-28 2002-09-25 Sales de amonio cuaternarias de omega-aminoalquilamidas de ácidos R-2-arilpropiónicos y composiciones farmacéuticas que las contienen
JP2003532442A JP4405801B2 (ja) 2001-09-28 2002-09-25 Ｒ−２−アリール−プロピオン酸のオメガ−アミノアルキルアミドの４級アンモニウム塩及びそれらを含有する医薬組成物
PCT/EP2002/010746 WO2003029187A1 (en) 2001-09-28 2002-09-25 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them
RU2004113099/04A RU2291857C2 (ru) 2001-09-28 2002-09-25 Четвертичные аммониевые соли омега-аминоалкиламидов r-2-арилпропионовых кислот и содержащие их фармацевтические составы
PT02777207T PT1430020E (pt) 2001-09-28 2002-09-25 Sais de amónio quaternário de omega-aminoalquilamidas de ácidos r-2-arilpropiónicos e composições farmacêuticas que os contêm
SI200231073A SI1430020T1 (sl) 2001-09-28 2002-09-25 Kvaternarne amonijeve soli omega-aminoalkilamidov r-2-aril-propionskih kislin in farmacevtski sestavki, ki jih vsebujejo
EP02777207.8A EP1430020B1 (en) 2001-09-28 2002-09-25 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them
PL369511A PL214275B1 (pl) 2001-09-28 2002-09-25 Czwartorzedowe sole amoniowe omega-aminoalkiloamidów kwasów R-2-arylo-propionowych, zawierajace je kompozycje farmaceutyczne i sposób ich wytwarzania
CA2458035A CA2458035C (en) 2001-09-28 2002-09-25 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them
NO20041609A NO328879B1 (no) 2001-09-28 2004-04-20 R-2-aryl-propionamidforbindelser, fremgangsmate for deres fremstilling og farmasoytiske preparater som inneholder disse
CY20161100463T CY1117657T1 (el) 2001-09-28 2016-05-27 Αλατα τεταρτοταγους αμμωνιου ωμεγα-αμινοαλκυλαμιδιων των r-2-αρυλ-προπιονικων οξεων και φαρμακευτικες συνθεσεις που περιεχουν αυτα

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI002025A ITMI20012025A1 (it) 2001-09-28 2001-09-28 Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono

Publications (2)

Publication Number Publication Date
ITMI20012025A0 true ITMI20012025A0 (it) 2001-09-28
ITMI20012025A1 ITMI20012025A1 (it) 2003-03-28

Family

ID=11448449

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001MI002025A ITMI20012025A1 (it) 2001-09-28 2001-09-28 Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono

Country Status (16)

Country Link
US (1) US7026510B2 (it)
EP (1) EP1430020B1 (it)
JP (1) JP4405801B2 (it)
AU (1) AU2002338784B2 (it)
CA (1) CA2458035C (it)
CY (1) CY1117657T1 (it)
DK (1) DK1430020T3 (it)
ES (1) ES2573531T3 (it)
HU (1) HU230541B1 (it)
IT (1) ITMI20012025A1 (it)
NO (1) NO328879B1 (it)
PL (1) PL214275B1 (it)
PT (1) PT1430020E (it)
RU (1) RU2291857C2 (it)
SI (1) SI1430020T1 (it)
WO (1) WO2003029187A1 (it)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1457485A1 (en) * 2003-03-14 2004-09-15 Dompé S.P.A. Sulfonic acids, their derivatives and pharmaceutical compositions containing them
WO2004091597A2 (en) * 2003-04-15 2004-10-28 Pharmacia & Upjohn Company Llc Method of treating irritable bowel syndrome (ibs)
ES2333445T3 (es) * 2004-03-23 2010-02-22 Dompe' S.P.A. Derivados del acido 2-fenilpropionico y composiciones farmaceuticas que los contienen.
DK1856031T3 (da) * 2004-12-15 2009-06-29 Dompe Pha R Ma Spa Res & Mfg 2-arylpropionsyrederivater og farmaceutiske sammensætninger indeholdende disse
EP1739078A1 (de) 2005-05-30 2007-01-03 Jerini AG C5a-Rezeptor-Antagonisten
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
WO2008010025A1 (en) * 2006-07-18 2008-01-24 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate
WO2008012605A1 (en) * 2006-07-27 2008-01-31 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of ketoprofen and related compounds with very fast skin penetration rate
CN104610077B (zh) * 2006-07-27 2020-04-14 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药
CN103772259B (zh) * 2006-08-08 2016-08-31 于崇曦 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药
EP2049482B1 (en) * 2006-08-08 2015-10-21 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate
CN103772258B (zh) * 2006-08-08 2016-09-28 于崇曦 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药
EP2054384A4 (en) * 2006-08-15 2010-11-03 Techfields Biochem Co Ltd POSITIVELY LOADED WATER-SOLUBLE PRODRUGS OF ARYL AND HETEROARYLPROPIONIC ACIDS WITH A VERY FAST SKIN PUNCHING RATE
AU2013206218B2 (en) * 2006-08-15 2016-06-30 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate
PL2170826T3 (pl) 2007-06-04 2022-09-05 Techfields Inc Proleki nsaia o bardzo wysokim współczynniku przenikania przez skórę i błony oraz ich nowe zastosowania lecznicze
EP2201006B1 (en) * 2007-10-18 2011-03-09 Dompé S.p.a. (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
CA3213470A1 (en) 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
WO2010075257A1 (en) 2008-12-22 2010-07-01 Chemocentryx, Inc. C5ar antagonists
WO2011006073A1 (en) 2009-07-10 2011-01-13 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
KR20130073822A (ko) * 2011-12-23 2013-07-03 가부시키가이샤 한도오따이 에네루기 켄큐쇼 이온 액체, 비수 전해질 및 축전 장치
JP5940036B2 (ja) * 2013-10-08 2016-06-29 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ
CN106659697B (zh) * 2014-05-30 2022-03-29 斯菲叶尔制药私有公司 作为抗结核剂的化合物
ES2926828T3 (es) 2014-09-29 2022-10-28 Chemocentryx Inc Procesos e intermedios en la preparación de antagonistas de C5aR
US11021443B2 (en) * 2015-08-03 2021-06-01 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
TWI791423B (zh) 2016-01-14 2023-02-11 美商卡默森屈有限公司 C3腎絲球病變之治療方法
CN109310686B (zh) 2016-04-04 2022-06-21 凯莫森特里克斯股份有限公司 可溶性C5aR拮抗剂
EP3630774B1 (en) 2017-05-31 2022-11-23 ChemoCentryx, Inc. 5-5 fused rings as c5a inhibitors
MA48803A (fr) 2017-05-31 2020-04-08 Chemocentryx Inc Cycles 6-5 fusionnés utilisés en tant qu'inhibiteurs de c5a
US20190144389A1 (en) 2017-10-30 2019-05-16 Chemocentryx, Inc. Deuterated compounds as immunomodulators
CA3086111A1 (en) 2017-12-22 2019-06-27 Chemocentryx, Inc. Diaryl substituted 5,5-fused ring compounds as c5ar inhibitors
KR20200109316A (ko) 2017-12-22 2020-09-22 케모센트릭스, 인크. C5aR 억제제로서의 디아릴 치환된 6,5-융합 고리 화합물
US20190300526A1 (en) 2018-04-02 2019-10-03 Chemocentryx, Inc. PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS
US20200231545A1 (en) * 2019-01-03 2020-07-23 President And Fellows Of Harvard College Charged ion channel blockers and methods for use thereof
MA55320A (fr) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueurs de canaux ioniques substitués par un ester et méthodes d'utilisation
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2022525856A (ja) 2019-03-11 2022-05-20 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3155586A1 (en) 2019-11-06 2021-05-14 Bridget M. Cole Charged ion channel blockers and methods for use
EP4054586A4 (en) 2019-11-06 2023-11-22 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
CN115279731A (zh) 2020-03-11 2022-11-01 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1593024A (it) 1968-09-18 1970-05-25
IT1090782B (it) * 1977-11-30 1985-06-26 Menarini Sas 2 4 bifenilil 2 dietilamino alchil propionamide suoi sali e procedimenti di fabbricazione relativi
IT1317826B1 (it) * 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
US20020160988A1 (en) * 2001-02-20 2002-10-31 Israel Institute For Biological Research Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
ITMI20010395A1 (it) * 2001-02-27 2002-08-27 Dompe Spa Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate

Also Published As

Publication number Publication date
HU230541B1 (hu) 2016-11-28
ITMI20012025A1 (it) 2003-03-28
JP2005504121A (ja) 2005-02-10
JP4405801B2 (ja) 2010-01-27
DK1430020T3 (en) 2016-05-30
WO2003029187A1 (en) 2003-04-10
PL369511A1 (en) 2005-04-18
PT1430020E (pt) 2016-06-08
CY1117657T1 (el) 2017-05-17
NO20041609L (no) 2004-04-20
PL214275B1 (pl) 2013-07-31
US7026510B2 (en) 2006-04-11
RU2291857C2 (ru) 2007-01-20
CA2458035A1 (en) 2003-04-10
RU2004113099A (ru) 2005-09-10
HUP0401763A3 (en) 2006-01-30
NO328879B1 (no) 2010-06-07
EP1430020B1 (en) 2016-03-02
HUP0401763A2 (hu) 2004-12-28
SI1430020T1 (sl) 2016-06-30
US20040266870A1 (en) 2004-12-30
EP1430020A1 (en) 2004-06-23
AU2002338784B2 (en) 2008-08-14
ES2573531T3 (es) 2016-06-08
CA2458035C (en) 2011-04-12

Similar Documents

Publication Publication Date Title
ITMI20012025A0 (it) Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono
NO2023030I1 (no) Apixaban and pharmaceutical acceptable salts thereof
CY2009011I1 (el) Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης
IT1319694B1 (it) Sali di iodonio come donatori di acidi latenti.
DE60220475D1 (de) Verfahren zur Herstellung quaternärer Ammoniumsalze von Hydroxycarbonsäuren und quaternärer Ammoniumsalze anorganischer Säuren
ATE395053T1 (de) Pharmazeutische salze von 1-phenyl-3- dimethylamino-propan-verbindungen
ATE449079T1 (de) Pharmazeutische zusammensetzungen beinhaltend kristallsalze von 7-ä4-(4-fluorophenyl)-6- isopropyl-2-
NO20014409L (no) Dimere forbindelser og deres anvendelse som inhibitorer av neuraminidase
NO20014074D0 (no) Farmasoytisk preparat inneholdende protonpumpeinhibitorer
DE60325968D1 (de) Prodrugs von exzitatorischen aminosäuren
IS8232A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
IS7061A (is) Tvívetnis N-setnir og a-setnir dífenýlalkoxý ediksýru amínó alkýl esterar og lyf sem innihalda téð efnasambönd
DE50006898D1 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
ITMI991757A0 (it) Dispersioni acquose di acidi percarbossilici
PT1321471E (pt) Novo processo de sintese do perindopril e dos seus sais aceitaveis sob o ponto de vista farmaceutico
IT1290448B1 (it) Nimesulide sale di colina,metodo di preparazione e composizioni farmaceutiche che lo contengono
ITMI20031326A0 (it) Sali di acidi idrossicinnamici e di idrossistilbeni otticamente attivi
NO20013673L (no) Acetyleniske bicykliske orto-sulfonamido -og fosfinsyreamidoheteroarylhydroksamsyrer som TACE-inhibitorer
IT1276173B1 (it) Sali di ammonio di acidi urs-12-enoici e composizioni farmaceutiche che li contengono
EE200100381A (et) Morfolinobensamiidi uued soolad
ATE356111T1 (de) Prodrugs von exzitatorischen aminosäuren
NO20015042D0 (no) Fremgangsmåter for fremstilling av optisk aktive aminosyrederivater
PT1216253E (pt) Processo para a preparacao de acidos metileno bisfosfonicos e seus sais
DE50003909D1 (de) Phosphorsäuresalz eines aromatischen diamins
IT1213059B (it) Sali imidazolici di acidi arilalcanoici antiflogistica,antipiretica, analgesica, loro preparazione e composizioni farmaceutiche che licontengono.